Impaired efferocytosis by monocytes and monocyte-derived macrophages in patients with poorly controlled type 2 diabetes

Figure 2 Percentage of classical monocytes and macrophage CD14 expression were decreased in type 2 diabetes patients. A: Percentages of different monocyte subsets (classical, intermediate and nonclassical monocytes); B: The percentage of CD14⁺ macrophages in control subjects and diabetes patients was determined by flow cytometry; C: The median fluorescence intensity of CD14 in macrophages from control subjects and diabetes patients. The data are the mean ± SD. ^aP < 0.05, ^bP < 0.01 from paired t test. T2D: Type 2 diabetes; MFI: Median fluorescence intensity.